JPWO2020180942A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020180942A5 JPWO2020180942A5 JP2021552742A JP2021552742A JPWO2020180942A5 JP WO2020180942 A5 JPWO2020180942 A5 JP WO2020180942A5 JP 2021552742 A JP2021552742 A JP 2021552742A JP 2021552742 A JP2021552742 A JP 2021552742A JP WO2020180942 A5 JPWO2020180942 A5 JP WO2020180942A5
- Authority
- JP
- Japan
- Prior art keywords
- abiraterone
- oil
- pharmaceutically acceptable
- decanoate
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962814568P | 2019-03-06 | 2019-03-06 | |
| US62/814,568 | 2019-03-06 | ||
| US201962849259P | 2019-05-17 | 2019-05-17 | |
| US62/849,259 | 2019-05-17 | ||
| PCT/US2020/020915 WO2020180942A1 (en) | 2019-03-06 | 2020-03-04 | Abiraterone prodrugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523819A JP2022523819A (ja) | 2022-04-26 |
| JPWO2020180942A5 true JPWO2020180942A5 (zh) | 2023-03-09 |
Family
ID=70190090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552742A Pending JP2022523819A (ja) | 2019-03-06 | 2020-03-04 | アビラテロンプロドラッグ |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10792292B2 (zh) |
| EP (2) | EP4286006A3 (zh) |
| JP (1) | JP2022523819A (zh) |
| KR (1) | KR20210136072A (zh) |
| CN (1) | CN114026106A (zh) |
| AU (1) | AU2020232706A1 (zh) |
| BR (1) | BR112021017377A2 (zh) |
| CA (1) | CA3131034A1 (zh) |
| DK (1) | DK3935068T3 (zh) |
| ES (1) | ES2964818T3 (zh) |
| IL (1) | IL286048A (zh) |
| MX (1) | MX2021010553A (zh) |
| PL (1) | PL3935068T3 (zh) |
| WO (1) | WO2020180942A1 (zh) |
| ZA (1) | ZA202107278B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4286006A3 (en) * | 2019-03-06 | 2024-03-20 | Propella Therapeutics, Inc. | Abiraterone prodrugs |
| US20210202095A1 (en) * | 2019-12-26 | 2021-07-01 | Cerner Innovation, Inc. | Decision support application for pcos |
| EP4208171A1 (en) * | 2020-09-02 | 2023-07-12 | Propella Therapeutics, Inc. | Abiraterone prodrugs |
| CN113929727A (zh) * | 2020-09-28 | 2022-01-14 | 南京易腾药物研究院有限公司 | 阿比特龙酯类衍生物及其制备方法和应用 |
| JP2024506382A (ja) | 2021-02-15 | 2024-02-13 | プロペラ セラピューティクス インコーポレイテッド | アビラテロンプロドラッグ |
| WO2023038933A1 (en) | 2021-09-08 | 2023-03-16 | Propella Therapeutics, Inc. | Oral abiraterone formulations |
| WO2023167783A1 (en) | 2022-03-01 | 2023-09-07 | Propella Therapeutics, Inc. | Abiraterone decanoate prodrugs and use in therapy |
| CN116046950A (zh) * | 2023-01-18 | 2023-05-02 | 河北省药品医疗器械检验研究院(河北省化妆品检验研究中心) | 一种检测醋酸阿比特龙中5种杂质的方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5604213A (en) | 1992-03-31 | 1997-02-18 | British Technology Group Limited | 17-substituted steroids useful in cancer treatment |
| GB0418900D0 (en) * | 2004-08-24 | 2004-09-29 | Btg Int Ltd | Novel salt forms |
| US20080051380A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
| US20090124587A1 (en) | 2007-07-12 | 2009-05-14 | Auerbach Alan H | METHODS FOR TREATING CANCER USING 17alpha-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| AU2010210422A1 (en) | 2009-02-05 | 2011-08-18 | Tokai Pharmaceuticals, Inc. | Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens |
| WO2011066582A1 (en) | 2009-11-30 | 2011-06-03 | Harbor Biosciences, Inc. | Anticancer compounds and screening method |
| PL2766381T3 (pl) | 2011-10-10 | 2016-12-30 | Sposób wytwarzania steroidów podstawionych w pozycji 17 | |
| US20140079636A1 (en) | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| WO2013159225A1 (en) | 2012-04-23 | 2013-10-31 | Alphora Research Inc. | Process for preparation of 17-substituted steroids |
| WO2014009434A1 (en) | 2012-07-11 | 2014-01-16 | Sandoz Ag | Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate |
| US20140011992A1 (en) | 2012-12-20 | 2014-01-09 | Crystal Pharma, S.A.U. | Synthesis of abiraterone and related compounds |
| US20150337003A1 (en) | 2013-01-18 | 2015-11-26 | Cortendo Ab (Publ) | Abiraterone and analogs thereof for the treatment of diseases associated with cortisol overproduction |
| US20150246060A1 (en) | 2013-03-15 | 2015-09-03 | Iceutica Inc. | Abiraterone Acetate Formulation and Methods of Use |
| TWI731321B (zh) | 2013-03-15 | 2021-06-21 | 阿聯商太陽法瑪全球有限公司 | 醋酸阿比特龍配方 |
| WO2015038649A1 (en) | 2013-09-10 | 2015-03-19 | Synta Pharmaceuticals Corp. | Targeted therapeutics |
| US20150157646A1 (en) | 2013-09-27 | 2015-06-11 | Iceutica Inc. | Abiraterone Steroid Formulation |
| MA39481A (fr) | 2014-03-03 | 2015-09-11 | Synta Pharmaceuticals Corp | Thérapies ciblées |
| EP3131586A4 (en) | 2014-03-18 | 2017-10-25 | Madrigal Pharmaceuticals, Inc. | Targeted therapeutics |
| CN104017045B (zh) * | 2014-06-23 | 2016-01-13 | 广州艾格生物科技有限公司 | 甾体cyp17抑制剂的新型药物前体及其应用、制备方法 |
| US9937259B2 (en) | 2014-06-27 | 2018-04-10 | Zhuhai Beihai Biotech Co., Ltd. | Abiraterone derivatives and non-covalent complexes with albumin |
| KR102617537B1 (ko) | 2014-09-18 | 2023-12-22 | 썬 파마슈티칼 인더스트리스 리미티드 | 아비라테론 아세테이트 제제 및 사용 방법 |
| CN104356191A (zh) | 2014-09-29 | 2015-02-18 | 上海延安药业（湖北）有限公司 | 阿比特龙单琥珀酸酯及其制备方法 |
| WO2016082792A1 (zh) | 2014-11-28 | 2016-06-02 | 四川海思科制药有限公司 | 一种阿比特龙衍生物及其制备方法和医药用途 |
| CN104447394B (zh) * | 2014-12-17 | 2017-01-18 | 成都傲飞生物化学品有限责任公司 | 一种乌苯美司的新型合成工艺 |
| CN104710499A (zh) | 2015-02-15 | 2015-06-17 | 重庆医药工业研究院有限责任公司 | 一种丙酸阿比特龙的晶型及其制备方法 |
| AU2016379454B2 (en) | 2015-12-23 | 2021-01-28 | The University Of British Columbia | Lipid-linked prodrugs |
| CN108541255B (zh) | 2016-02-02 | 2019-06-14 | 深圳市塔吉瑞生物医药有限公司 | 一种甾体类化合物及包含该化合物的组合物及其用途 |
| WO2018071544A1 (en) | 2016-10-11 | 2018-04-19 | Zhuhai Beihai Biotech Co., Ltd. | Abiraterone derivative and formulations thereof |
| CN106977577A (zh) | 2017-04-21 | 2017-07-25 | 湖南师范大学 | 两类阿比特龙衍生物的合成 |
| EP4286006A3 (en) * | 2019-03-06 | 2024-03-20 | Propella Therapeutics, Inc. | Abiraterone prodrugs |
-
2020
- 2020-03-04 EP EP23188119.4A patent/EP4286006A3/en active Pending
- 2020-03-04 DK DK20717363.4T patent/DK3935068T3/da active
- 2020-03-04 KR KR1020217032021A patent/KR20210136072A/ko unknown
- 2020-03-04 JP JP2021552742A patent/JP2022523819A/ja active Pending
- 2020-03-04 WO PCT/US2020/020915 patent/WO2020180942A1/en unknown
- 2020-03-04 MX MX2021010553A patent/MX2021010553A/es unknown
- 2020-03-04 EP EP20717363.4A patent/EP3935068B1/en active Active
- 2020-03-04 US US16/808,912 patent/US10792292B2/en active Active
- 2020-03-04 CA CA3131034A patent/CA3131034A1/en active Pending
- 2020-03-04 BR BR112021017377A patent/BR112021017377A2/pt unknown
- 2020-03-04 PL PL20717363.4T patent/PL3935068T3/pl unknown
- 2020-03-04 CN CN202080032112.9A patent/CN114026106A/zh active Pending
- 2020-03-04 AU AU2020232706A patent/AU2020232706A1/en active Pending
- 2020-03-04 ES ES20717363T patent/ES2964818T3/es active Active
- 2020-08-10 US US16/989,304 patent/US11559534B2/en active Active
-
2021
- 2021-09-01 IL IL286048A patent/IL286048A/en unknown
- 2021-09-28 ZA ZA2021/07278A patent/ZA202107278B/en unknown
-
2023
- 2023-01-19 US US18/098,798 patent/US20230233582A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11559534B2 (en) | Abiraterone prodrugs | |
| JP6740497B2 (ja) | 癌を治療するための方法及び組成物 | |
| US11957696B2 (en) | Abiraterone prodrugs | |
| CA2908571C (en) | Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives | |
| US20240050447A1 (en) | Abiraterone prodrugs | |
| WO2023038933A1 (en) | Oral abiraterone formulations | |
| JPWO2020180942A5 (zh) | ||
| JP2018530597A (ja) | フルベストラント組成物 | |
| WO2023167783A1 (en) | Abiraterone decanoate prodrugs and use in therapy | |
| US11707467B2 (en) | (17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods of their preparation and use | |
| WO2024107928A1 (en) | Abiraterone decanoate composition and use in therapy |